PET imaging with 18F-florbetaben IDs Alzheimer's

04/2/2013 | MolecularImaging.net

Uptake of 18F-florbetaben on PET imaging scans was higher in the cerebral cortex of patients with Alzheimer's disease than in healthy study participants, according to a study published in the Journal of Nuclear Medicine. Researchers used a kinetic compartment theory of analysis for this study. "Compartment kinetic model-based quantification of [beta-amyloid] binding from 18F-florbetaben PET data is feasible, and all [beta-amyloid] binding parameters, including those by the reference tissue model and the practically useful SUVR, are excellent in discriminating between beta-amyloid–positive–and–negative scans," researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ